Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Sumatra Biorenewables
AddedFeb 18, 2024
UpdatedJun 18, 2026
Sumatra Biorenewables

Sumatra Biorenewables

Sumatra Biorenewables, an Iowa-based startup, specializes in producing 3HDA, a novel biobased monomer for tailored material production.

HQ
Ames, IA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Sumatra Biorenewables, based in Ames, Iowa, specializes in the production of trans-3-hexenedioic acid (3HDA), a novel biobased monomer derived from biologically-produced muconic acid. The company's innovative approach enables the creation of materials with tailored functional properties by introducing 3HDA into polyamides or polyesters through copolymerization or compounding.

This chemical startup's technology allows for the production of advanced materials without altering the intrinsic nature of the polymeric material. Sumatra Biorenewables' focus on biobased monomers positions them at the forefront of sustainable chemical manufacturing, contributing to the development of eco-friendly materials with customizable properties.

Sumatra Biorenewables - Similar Companies

Varifas Biorenewables logo

Varifas Biorenewables

SusTerea Biorenewables logo

SusTerea Biorenewables

Mango Materials logo

Mango Materials

mangomaterials.com

OmegaChea logo

OmegaChea

Ecovia Renewables logo

Ecovia Renewables

Prisma Renewable Composites logo

Prisma Renewable Composites

Genomatica logo

Genomatica

genomatica.com

Manus Bio logo

Manus Bio

Trillium Renewable Chemicals logo

Trillium Renewable Chemicals

BioLogiQ logo

BioLogiQ

biologiq.com

Integrity Bio-Chemicals logo

Integrity Bio-Chemicals

Terramer logo

Terramer

terramerinc.com

FiberX logo

FiberX

fiberxproducts.com

Biomade logo

Biomade

NatureWorks logo

NatureWorks

natureworksllc.com

Sumatra Biorenewables - Quick Facts

Who are Sumatra Biorenewables' competitors?

Companies similar to Sumatra Biorenewables include Varifas Biorenewables, SusTerea Biorenewables, Mango Materials and OmegaChea.

When was Sumatra Biorenewables founded?

Sumatra Biorenewables was founded in 2015.

Where is Sumatra Biorenewables' headquarters located?

Sumatra Biorenewables' headquarters is located in Ames, IA, US.

When was Sumatra Biorenewables' last funding round?

Sumatra Biorenewables' most recent funding round was for $225k (USD) in June 2018.

How much has Sumatra Biorenewables raised to-date?

As of Jun 25, 2018, Sumatra Biorenewables has raised a total of $225k (USD).

How many employees does Sumatra Biorenewables have?

Sumatra Biorenewables has 6 employees as of Feb 4, 2024.

Sumatra Biorenewables - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Model
  • Manufacturing
Revenue
  • Transactional
Customer
  • Enterprise
Main Product
  • Biobased Monomers
Tags
  • Biotech
  • Cleantech
NAICS
  • 320000Manufacturing
  • 325300Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing
  • 325320Pesticide and Other Agricultural Chemical Manufacturing
  • 325000Chemical Manufacturing
SIC
  • 2870Agricultural Chemicals
  • 2879Pesticides And Agricultural Chemicals, Not Elsewhere Classified
  • 2800Chemicals And Allied Products
Show 2 more industry codes
SIC
  • 2890Miscellaneous Chemical Products
  • 2899Chemicals And Chemical Preparations, Not Elsewhere Classified